title: Putting the E (evidence) in a new Era for myeloma.
authors.affiliation: Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA. jlkaufm@emory.edu
authors.forename: Jonathan L
authors.initials: JL
authors.lastname: Kaufman
authors.forename: Sagar
authors.initials: S
authors.lastname: Lonial
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D055317:Evidence-Based Practice / Q000379:methods / Q000639:trends*; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000401:mortality; D009101:Multiple Myeloma / Q000401:mortality / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D000069283:Rituximab; D016019:Survival Analysis
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab